![Ji-Hoon Park](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ursprung des Netzwerks ersten Grades von Ji-Hoon Park
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
TeraImmune, Inc.
![]() TeraImmune, Inc. BiotechnologyHealth Technology TeraImmune, Inc. engages in the development of customized cell therapies for autoimmune diseases using the patient’s own Treg cells. Its pipeline includes Hemophilia A, Multiple Sclerosis, and B cell lymphoma. The company was founded by Yong-Chan Kim and Ji-Hoon Park in 2016 and is headquartered in Gaithersburg, MD.
1
| Subsidiary | Biotechnology | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Ji-Hoon Park
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
BAUDAX BIO, INC. | Pharmaceuticals: Major | Director/Board Member | |
Chungnam National University | College/University | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 2 |
Südkorea | 2 |
Sektoral
Health Technology | 2 |
Consumer Services | 2 |
Operativ
Director/Board Member | 2 |
Chief Executive Officer | 1 |
Founder | 1 |
Independent Dir/Board Member | 1 |
Doctorate Degree | 1 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Yong-Chan Kim | 3 |
- Börse
- Insiders
- Ji-Hoon Park
- Unternehmensverbindungen